Financials
- Market Capitalization 5.39 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.81
Relación precio/flujo de caja
781.65
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1246 | BLTE Belite Bio Inc - American Depositary Shares | 147.03 USD | -1.54% | -5.14% | +4.41% | +128.59% | 5.78 B USD | ||
| 1267 | ERAS Erasca, Inc. - Common Stock | 17.90 USD | -3.40% | -5.14% | +27.22% | +1126.03% | 5.57 B USD | ||
| 1301 | TVTX Travere Therapeutics, Inc. - Common Stock | 56.29 USD | -0.53% | -2.58% | +6.63% | +95.66% | 5.23 B USD | ||
| 1329 | CELC Celcuity Inc. - Common Stock | 103.79 USD | -3.52% | -6.02% | +15.36% | +649.39% | 5.06 B USD |